Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsBy securing the WHO’s elite global benchmark, Indonesia has transformed regulatory trust from a technical achievement into a strategic asset, proving that middle-income nations can lead the world in global health security.
US President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government's Medicaid program and for cash payers, in his latest bid to align US costs with those in other wealthy nations.
President Donald Trump on Thursday unveiled a fresh round of punishing tariffs on a broad range of imported goods, including 100 percent duties on branded drugs and 25 percent tariffs on heavy-duty trucks, set to come into force next week.
The military will begin manufacturing medicines for public distribution under a new agreement, officials said on Tuesday, in the latest expansion of the armed forces' role in civilian affairs since President Prabowo Subianto took office.
The Defense Ministry is planning to utilize medical laboratories owned by the Indonesian Military’s (TNI) three branches to produce drugs and distribute them through the Red and White Village Cooperatives Program in a bid to lower medicine prices and improve distribution.
Indian Ambassador to Indonesia Sandeep Chakravorty says at least three Indian pharmaceutical companies are eyeing investment opportunities in Indonesia, including MSN Laboratories and Dr. Reddy’s Laboratories.
Indonesia’s biggest pharmaceutical company plans to close five factories within the next two or three years in a measure that its director of production and supply chain attributed to the need to ensure sustainability.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.